ArticleJCO precision oncology2025

Pembrolizumab Monotherapy for Early-Stage Triple-Negative Breast Cancer in a Patient With Lynch Syndrome.

Sonia Gowda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.